|
|
Article: S-P's Aerius reduces allergy symptoms.
- Article from:
- Pharma Marketletter
- Article date:
- June 16, 2008
CopyrightCOPYRIGHT 2008 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
New data presented at the Congress of the European Academy of Allergology and Clinical Immunology in Barcelona, Spain, demonstrate that US drug major Schering-Plough's Aerius (desloratadine) significantly reduces allergy symptoms, including nasal congestion, sneezing, rhinorrhea, nasal pruritus and ocular pruritus, in patients with intermittent allergic rhinitis who experience symptoms lasting less than four days per week or less than four weeks per year.
According to the study in patients with IAR, those receiving Aerius 5mg for a 15-day treatment period experienced significant reduction in total symptom severity score from baseline versus placebo (-3.01 vs ...